Pre-Funded Warrants (March 2026 registered direct offering)
Issued 2026
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Services-Computer Processing & Data PreparationIndustry: Medical - PharmaceuticalsCountry: USExchange: Nasdaq
DilutionScan read 18 of Paranovus Entertainment Technology Ltd.'s SEC filings and found 2 warrant series, 7 convertibles, 2 ATM programs, 3 shelf registrations and 7 completed offerings on file for PAVS. The latest dilution event on file is an offering on Jul 2, 2026. Analysis updated Sep 4, 2026.
PAVS
Going-concern warning and massive dilution
Paranovus is a micro-cap shell in severe distress. Revenue collapsed from $23.3 million in 2022 to just $72,000 in 2024, a 98.9 percent drop. The company lost $7.9 million last year and burns $2.7 million in cash annually. With only $5.0 million in cash and $2.4 million in debt, the cash runway is tight at 7.2 months.
Raise routes on file: effective shelf · latest dilution event 124 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jul 2, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2025
Total capacity
Sold to date
Issued 2026
Total capacity
Sold to date
Issued 2025
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Medical - Pharmaceuticals, then the closest in size. All tickers A to Z